retatrutide side effects cancer Retatrutide—A Game Changer in Obesity Pharmacotherapy Incretin triple agonist retatrutide (LY3437943)

GLP-1 Receptor Activation Glucagon-like peptide-1, or GLP-1, serves as the foundation of modern weight loss medications

Localized strategies may involve cost-effective therapies, generic utilization, and tailored care models to suit diverse resource environments

If refrigeration is unavailable briefly, keep the vial as cool and dark as possible

Joseph Zucchi, PA-C, MPAS, is a board-certified physician associate specializing in obesity medicine and clinical supervisor at Transition Medical Weight Loss in Salem, New Hampshire

Patients with bilateral MB injury or small MB were more likely to also have posterior hypothalamus injury